UBS AM’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-244,631
| Closed | -$16.7M | – | 2816 |
|
|
2022
Q3 | $16.7M | Sell |
244,631
-165,292
| -40% | -$11.3M | 0.01% | 809 |
|
|
2022
Q2 | $13.1M | Buy |
409,923
+333,449
| +436% | +$10.7M | 0.01% | 854 |
|
|
2022
Q1 | $2.65M | Buy |
76,474
+1,349
| +2% | +$46.7K | ﹤0.01% | 1646 |
|
|
2021
Q4 | $2.2M | Hold |
75,125
| – | – | ﹤0.01% | 1826 |
|
|
2021
Q3 | $1.91M | Buy |
75,125
+854
| +1% | +$21.8K | ﹤0.01% | 1861 |
|
|
2021
Q2 | $2.6M | Sell |
74,271
-17,611
| -19% | -$617K | ﹤0.01% | 1732 |
|
|
2021
Q1 | $3.74M | Buy |
91,882
+2,370
| +3% | +$96.6K | ﹤0.01% | 1475 |
|
|
2020
Q4 | $3.88M | Buy |
89,512
+15,293
| +21% | +$662K | ﹤0.01% | 1398 |
|
|
2020
Q3 | $4.09M | Buy |
74,219
+1,958
| +3% | +$108K | ﹤0.01% | 1231 |
|
|
2020
Q2 | $4.56M | Buy |
72,261
+282
| +0.4% | +$17.8K | ﹤0.01% | 1151 |
|
|
2020
Q1 | $3.68M | Buy |
71,979
+5,806
| +9% | +$297K | ﹤0.01% | 1169 |
|
|
2019
Q4 | $5.26M | Buy |
66,173
+4,828
| +8% | +$384K | ﹤0.01% | 1167 |
|
|
2019
Q3 | $2.98M | Buy |
61,345
+11,909
| +24% | +$578K | ﹤0.01% | 1425 |
|
|
2019
Q2 | $2.6M | Buy |
49,436
+11,313
| +30% | +$595K | ﹤0.01% | 1459 |
|
|
2019
Q1 | $2.02M | Sell |
38,123
-1,537
| -4% | -$81.4K | ﹤0.01% | 1516 |
|
|
2018
Q4 | $1.63M | Buy |
39,660
+8,014
| +25% | +$329K | ﹤0.01% | 1524 |
|
|
2018
Q3 | $1.2M | Buy |
31,646
+705
| +2% | +$26.8K | ﹤0.01% | 1737 |
|
|
2018
Q2 | $1.4M | Buy |
30,941
+1,049
| +4% | +$47.4K | ﹤0.01% | 1673 |
|
|
2018
Q1 | $1.44M | Buy |
29,892
+5,881
| +24% | +$284K | ﹤0.01% | 1625 |
|
|
2017
Q4 | $945K | Buy |
24,011
+16,511
| +220% | +$650K | ﹤0.01% | 1774 |
|
|
2017
Q3 | $233K | Hold |
7,500
| – | – | ﹤0.01% | 2181 |
|
|
2017
Q2 | $205K | Sell |
7,500
-8,692
| -54% | -$238K | ﹤0.01% | 2214 |
|
|
2017
Q1 | $597K | Buy |
+16,192
| New | +$597K | ﹤0.01% | 1803 |
|